Crosswinds Holdings Inc. Reports Q3 2017 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
367
Crosswinds Holdings Inc. Reports Q3 2017 Financial Results

TORONTO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Crosswinds Holdings Inc. (“Crosswinds” or the “Company”) (TSX: CWI ) today announced its financial results as at and for the three and nine months ended September 30, 2017.

Business Highlights 

  • The Company’s recorded a loss for the third quarter primarily driven by negative performance on its investment in Monarch Delaware Holdings LLC and its subsidiaries (“Monarch”) as a result of Hurricane Irma which made landfall in Florida in September 2017 combined with weak underwriting performance.
  • Crosswinds is in discussions regarding a sale of its joint venture investment in Monarch to its joint venture partner.  There can be no assurance such discussions will result in a transaction and any such transaction would be conditioned on definitive documentation and regulatory approval.
  • Crosswinds Re did not participate in 2017 Florida reinsurance renewals after determining that rates were insufficient for Crosswinds Re’s rate of return targets.
  • The Company implemented a normal course issuer bid in the third quarter as the Company believes this is currently the best use of its available capital.

Q3 2017 Financial Highlights

For the three months ended September 30, 2017, the Company reported: 

  • Net loss of $(2,593,144) or $(0.28) per common share (“Share”) compared to net loss of $(282,230) or $(0.05) per Share for the three months ended September 30, 2016. Until such time as (i) Monarch’s performance improves or a strategic change is made to this investment; and/or (ii) Crosswinds Re becomes active and profitable, the Company expects its revenues to be constrained;  
  • Share of loss from Monarch of $(2.4 million) compared to share of income of $0.1 million for the three months ended September 30, 2016;
  • Shareholders’ equity attributable to Crosswinds’ shareholders (or net book value 1 ) of $20.2 million or $2.19 per Share1 compared to $20.2 million or $3.81 per Share 1 at December 31, 2016; and
  • $0.7 million of the decrease in net book value 1 during the quarter represents unrealized foreign exchange loss on translating the USD denominated investment in Monarch into Canadian dollars for financial statement purposes in an environment where the Canadian dollar has strengthened.  The Monarch investment is subject to significant foreign currency fluctuations which are unrealized but can distort the investment performance. 

For the nine months ended September 30, 2017, the Company reported:

  • Net loss of $(3,961,054) or $(0.47) per Share compared to net loss of $(994,502) or $(0.17) per Share for the nine months ended September 30, 2016; and
  • Share of loss from Monarch of $(2.9) million compared to income of $0.3 million for the nine months ended September 30, 2016.

[1]  Net book value per share is a non-IFRS financial measure and is calculated as total shareholders’ equity under International Financial Reporting Standards (IFRS) divided by the number of common shares outstanding as at the period end.  See the cautionary statement regarding use of Non-IFRS financial measures at the end of this release.

Statement of Operations Highlights

     
  Three months ended Sept. 30 Nine months ended Sept. 30
In CAD thousands, except per Share amounts  2017 2016 2017 2016
Revenue $   105  $   110 $   361 $   319
Net results of investments (2,513) 117 (3,113) 260
Expenses (533) (495) (1,627) (1,526)
Net loss $(2,941) $ (268) (4,379) (947)
Non-controlling interest’s (income) loss 348 (14) 418 (48)
Net loss attributable to the shareholders of Crosswinds $(2,593) $ (282) (3,961) (995)
Net loss per Share $ (0.28) $ (0.05) $(0.47) $(0.17)
         

For the quarter ended September 30, 2017, the Company reported:

  • Cash of $7.9 million compared to $1.6 million at December 31, 2016 reflecting the completion of a rights offering in Q1 2017 and the monetization of Salbro in Q2 2017; and
  • Carrying value of $14.3 million for Monarch compared to $18.3 million at December 31, 2016. $1.3 million of the $4.0 million decrease in the carrying value of Monarch from December 31, 2016 to the end of Q3 2017 was attributable to foreign exchange fluctuations as a result of a strengthening Canadian dollar.

 Balance Sheet Highlights  

In CAD thousands, except per Share amounts September 30, 2017 December 31, 2016 December 31, 2014
Cash $  7,899 $  1,566 $  17,118
Investments in an associate and private entity 14,255 21,322 4,038
Other assets 206 202 44
Total Assets $ 22,360 $ 23,090 $  21,200
Total Liabilities (151) (277) 552
Total Shareholders’ Equity $ 22,209 $ 22,813 $  20,648
Non-controlling interests (2,036) (2,610)  
Shareholders’ Equity attributable to the shareholders of Crosswinds $20,173 $20,203  
Number of shares outstanding (millions) 9.2 5.3 5.3
Net book value per Share attributable to the shareholders of Crosswinds $ 2.19  $ 3.81 $  3.89
       

Financial Information

For a comprehensive review of the Company’s results, shareholders are encouraged to read the Company’s condensed interim consolidated financial statements and accompanying Interim Management’s Discussion and Analysis for the period ended September 30, 2017, copies of which will be available on the Company’s website at www.crosswindsinc.com  and on SEDAR at www.sedar.com .

Crosswinds Holdings Inc.  

Crosswinds is a publicly traded private equity firm and asset manager targeting strategic and opportunistic investments in the financial services sector with a particular focus on the insurance industry. 

More information

Colin King Tel: 1-800-439-5136 info@crosswindsinc.com   www.crosswindsinc.com  

Caution Regarding Forward-Looking Information This release includes certain forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue” or the negative thereof or variations thereon or similar terminology. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct.  These forward-looking statements are subject to a number of risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements. Reference should be made to the risk factors in the Company’s 2016 Annual Information Form, in the Management’s Discussion and Analysis for the year ended December 31, 2016 and in our other filings with Canadian securities regulators. Additional important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, interest rates, tax related matters, loss of personnel, reliance on key personnel, ability of the Company to generate positive future returns for investors, ability of the Company to execute its strategies from time to time; the receipt of any regulatory approvals or consents required from time to time.

Cautionary Statement Regarding the Use of Non-IFRS Financial Measures This news release makes reference to the net book value per share which is a non-IFRS financial measure both on a consolidated basis including non-controlling interests with respect to the Company’s investment in Monarch and on a non-consolidated basis attributable solely to the Company’s shareholders without non-controlling interests.  These measures are non-IFRS financial measures.  The Company calculates the net book values per Share as it believes it to be an important metric that shareholders use and frequently request and refer to because shareholders often view the Company as a holding company of investments. These non-IFRS financial measures do not have any standardized meaning prescribed by IFRS and therefore are unlikely to be comparable to a similar measure presented by other issuers.  This classification is not an IFRS measure and should not be considered either in isolation of, or as a substitute for, a measure prepared in accordance with IFRS.

Cautionary Statement Regarding the Valuation of Investments in Private Entities

For the periods prior to the sale of its investment in Salbro, fair values for this investment were determined by management using the appropriate valuation methodologies after considering the history and nature of the business, operating results and financial conditions, outlook and prospects, general economic, industry and market conditions, capital market and transaction market conditions, contractual rights relating to the investment, public market comparables, private market transaction multiples and, where applicable, other pertinent considerations. The process of valuing investments for which no active market exists is inevitably based on inherent uncertainties and the resulting values may differ from values that would have been used had an active market existed. The amounts at which the Company's investments in private entities could or are ultimately disposed of may differ from the fair value assigned and the differences could be material.         

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blade and Bow Drops Rare 30-Year-Old Cask Strength Expression

Updated Category News Views 19

Turning Heads with a Rich Pour Forget watering down—Blade and Bow's latest masterpiece, the 30-Year-Old Cask Strength Kentucky Straight Bourbon Whiskey, is all about power. This new offering hasn't seen a drop of water since it left the barrel, clocking in at a punchy 164.2 proof. That's right, folks, they haven't pulled any punches this time. Heading into November,...

Continue Reading
Ex-Guard Pushes Cost-Saving Grille Guards as Deer Season Hits

Updated Category News Views 0

Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...

Continue Reading
Domestic Violence Laws: A Broken Shield Revealed

Updated Category News Views 0

A Look at Where Policies Stumble Life's got no script for chaos, and you'd think the laws meant to protect folks from domestic violence would at least have a solid plan. Turns out, that's not always the case. Bloomberg Law just pulled back the curtain in a stinging investigation that exposes the gaping holes in these well-meaning policies. Why spill my morning coffee over...

Continue Reading
EWTN’s Docuseries 'In Jesus' Name' Explores Exorcisms

Updated Category News Views 50

The True Stories Behind Exorcisms In the complex landscape of media today, EWTN Studio's latest docuseries, In Jesus' Name, steps into the ring with tales that outstrip Hollywood's beloved fright flicks. Forget about the jumpscares and the special effects next to those greased-up eggs you're munching on. This series drills right to the bone of reality—a candid look at...

Continue Reading
Historic Williamsburg Loft Gets a Modern Makeover

Updated Category News Views 0

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Continue Reading
DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 68

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Infosys Award Recognizes Global Banking Innovation 2026

Updated Category News Views 23

Championing Banking Innovations Globally If there's one thing you can count on in the financial world, it's innovation pushing the boundaries of how we bank. The 13th edition of the Qorus-Infosys Finacle Banking Innovation Awards has once again proven that innovation is not just a buzzword but a real, transformative force in the global banking landscape. This year, they...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 51

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading

Top 5 Most Recently Viewed Articles

Clarametyx Biosciences Partners with CARB-X for Vaccine Innovation

Updated Category News Views 103

Clarametyx Biosciences Partners with CARB-X Clarametyx Biosciences Inc, a pioneering biotechnology firm, is making strides in the fight against bacterial infections linked to biofilms. Recently, the company announced a significant partnership with CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), an essential player in supporting...

Continue Reading
Nvidia and Intel's Bold Move Reshapes AI Semiconductor Landscape

Updated Category News Views 374

Introduction to Nvidia and Intel's Partnership In a groundbreaking development, shares of Intel Corp. witnessed a remarkable surge of 28%. This significant increase came after Nvidia Corp. announced an impressive $5 billion investment in Intel. This partnership aims to revolutionize the semiconductor landscape profoundly, signaling a critical turning point within the...

Continue Reading
Understanding the Wayne Memorial Hospital Data Breach

Updated Category News Views 177

Overview of the Data Breach Incident In recent news, Wayne Memorial Hospital has disclosed a significant data breach that has affected a large number of individuals. This hospital, well-known for providing a wide array of medical services, encountered a cybersecurity incident that compromised a vast range of sensitive personal information. The hack involved unauthorized...

Continue Reading
Investigation Launched by Faruqi & Faruqi for PDD Holdings

Updated Category News Views 61

Investigation Launched for PDD Holdings Investors Faruqi & Faruqi, LLP, a well-known firm in national securities law, is reaching out to investors of PDD Holdings who have suffered significant losses. If your losses exceed $100,000, don’t wait any longer—contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to explore your options. What’s...

Continue Reading
Mediaplanet's Campaign Promotes Prostate Health Awareness

Updated Category News Views 132

Raising Awareness About Prostate and Urological Health Men's health issues, particularly those related to prostate and urological functions, often remain shrouded in silence. This silence can be detrimental, as it can lead to late diagnoses and increased mortality rates. One key initiative aimed at combating this issue is the campaign from Mediaplanet, dedicated to urging...

Continue Reading